密西西比州医疗补助计划中影响人乳头瘤病毒(HPV)疫苗接种系列完成的因素
该研究分析2013-2018年密西西比州医疗补助计划行政索赔数据,纳入2014年1月1日至2017年6月30日启动HPV疫苗接种的18110名女性和18186名男性(9-26岁),评估12个月内完成适龄推荐剂次的情况。结果显示女性完成率为34%、男性为30%,启动年龄较小、管理式医疗计划、非裔美国人种族及由儿科医生启动接种与完成率相关。结论认为该州HPV疫苗接种系列完成率不理想,需加强教育和公共卫生项目。
要点
- 女性HPV疫苗系列完成率为34%,男性为30%。
- 启动年龄9-10岁和11-12岁者完成 odds 高于13-14岁者,15-26岁者完成 odds 较低。
- 管理式医疗计划(vs. 按服务付费)和非裔美国人种族(vs. 白人)的完成 odds 较低。
核心结论
- 密西西比州医疗补助计划中HPV疫苗接种系列完成率不理想,尽管该州HPV相关癌症发病率高。
- HPV疫苗系列完成受多种社会人口学因素影响。
- 需要强有力的教育和公共卫生项目来鼓励完成推荐剂次。
研究设计与样本
- 分析2013-2018年密西西比州医疗补助计划行政索赔数据。
- 纳入2014年1月1日至2017年6月30日期间启动HPV疫苗接种的9-26岁男女受益人,评估12个月内完成适龄推荐剂次的情况。
- 采用性别分层多变量逻辑回归分析疫苗系列完成的相关因素。
- 共纳入18110名女性和18186名男性启动者。
主要发现
- 疫苗系列完成率女性为34%,男性为30%。
- 启动年龄较小是两性疫苗系列完成的显著预测因素:9-10岁和11-12岁启动者完成 odds 较高,15-26岁启动者完成 odds 低于13-14岁启动者。
- 管理式医疗计划(vs. 按服务付费)和非裔美国人种族(vs. 白人)的女性和男性受益人完成疫苗系列的 odds 较低。
- 由儿科医生启动HPV疫苗系列的女性和男性受益人完成率最高。
- 大多数启动者属于11-12岁年龄组、非裔美国人种族、管理式医疗计划和密西西比中部公共卫生区域。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify factors associated with Human Papillomavirus (HPV) vaccine series completion among vaccine initiators in Mississippi Medicaid. METHODS: 2013-2018 Mississippi Medicaid administrative claims data were analyzed. Female and male beneficiaries aged 9 to 26 years who initiated HPV vaccination in the identification period were assessed for completion of age-appropriate number of recommended doses within a period of 12 months. Sex-stratified multivariable logistic regression was used to examine factors associated with HPV vaccine series completion in the study sample. RESULTS: A total of 18,110 female and 18,186 male beneficiaries initiated HPV vaccine between January 1, 2014 and June 30, 2017. Most of the initiators belonged to ages 11 to 12 years, African American race, managed care plans and Central Mississippi public health region. The vaccine series completion rate was 34% for females and 30% for males. Younger age at initiation was a significant predictor of vaccine series completion in both sexes. Specifically, initiators in age groups 9 to 10 and 11 to 12 years, respectively, had greater odds of completion, while initiators aged 15 to 26 years had lower odds of completion compared to initiators aged 13 to 14 years. Female and male beneficiaries in managed care plans (vs. fee-for-service) and of African American race (vs. Caucasians) had lower odds of completing the vaccine series. Female and male beneficiaries who initiated HPV vaccine series with a pediatrician had the highest completion rates. CONCLUSION: HPV vaccination series completion rate in Mississippi Medicaid was suboptimal despite the high HPV-related cancer incidence in the state. HPV vaccine series completion is influenced by various sociodemographic factors. There is a need for robust education and public health programs to encourage completion of recommended doses.
引用
- Inguva S, Barnard M, Ward LM, et al. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. Vaccine. 2020. PMID: 31980196. doi:10.1016/j.vaccine.2019.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。